Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Srinivas

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
Cancer Medicine|July 30, 2020
Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatmentSandy Srinivas, Ateesha F Mohamed, Sreevalsa Appukkuttan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 17, 2024
Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral programDivya A Parikh, Gladys M Rodriguez, Meera Ragavan, et al.
The Lancet. Oncology|February 29, 2024
<sup>68</sup>Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trialHeying Duan, Farshad Moradi, Guido A Davidzon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa regionWaleed A Hassen, Farrok A Karsan, Farhat Abbas, et al.
International Journal of Cancer|October 19, 2013
Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy eraSimon L Conti, I-Chun Thomas, Judith C Hagedorn, et al.
Clinical Genitourinary Cancer|November 11, 2015
Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic ModelSamer Salah, Jae-Lyun Lee, Antonio Rozzi, et al.
JCO Precision Oncology|November 6, 2025
Genomic Landscape and Outcomes of Renal Cell Carcinoma With Metastases to the PancreasMichael J Glover, Arya Ashok, Osama Khan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2021
PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate CancerLucia Baratto, Hong Song, Heying Duan, et al.
Cancer|June 19, 2009
Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 studyDavid J Vaughn, Sandy Srinivas, Walter M Stadler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 5, 2017
Appropriate Use Criteria for Bone Scintigraphy in Prostate and Breast Cancer: Summary and ExcerptsKevin J Donohoe, Erica J Cohen, Francesco Giammarile, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
Cancer Medicine|July 30, 2020
Patient and caregiver benefit-risk preferences for nonmetastatic castration-resistant prostate cancer treatmentSandy Srinivas, Ateesha F Mohamed, Sreevalsa Appukkuttan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 17, 2024
Lay healthcare worker financial toxicity intervention: a pilot financial toxicity screening and referral programDivya A Parikh, Gladys M Rodriguez, Meera Ragavan, et al.
The Lancet. Oncology|February 29, 2024
<sup>68</sup>Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trialHeying Duan, Farshad Moradi, Guido A Davidzon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 11, 2010
Modification and implementation of NCCN guidelines on prostate cancer in the Middle East and North Africa regionWaleed A Hassen, Farrok A Karsan, Farhat Abbas, et al.
International Journal of Cancer|October 19, 2013
Utilization of cytoreductive nephrectomy and patient survival in the targeted therapy eraSimon L Conti, I-Chun Thomas, Judith C Hagedorn, et al.
Clinical Genitourinary Cancer|November 11, 2015
Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic ModelSamer Salah, Jae-Lyun Lee, Antonio Rozzi, et al.
JCO Precision Oncology|November 6, 2025
Genomic Landscape and Outcomes of Renal Cell Carcinoma With Metastases to the PancreasMichael J Glover, Arya Ashok, Osama Khan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 6, 2021
PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate CancerLucia Baratto, Hong Song, Heying Duan, et al.
Cancer|June 19, 2009
Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 studyDavid J Vaughn, Sandy Srinivas, Walter M Stadler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 5, 2017
Appropriate Use Criteria for Bone Scintigraphy in Prostate and Breast Cancer: Summary and ExcerptsKevin J Donohoe, Erica J Cohen, Francesco Giammarile, et al.
Pageof 16